.Vertex's effort to manage a rare hereditary disease has attacked yet another problem. The biotech t...
.Vir Medical's second-quarter incomes document wasn't short of big news. The firm invited a triad of...
.Galapagos has stopped briefly enrollment in a test of a BCMA-directed CAR-T tissue treatment, pushi...
.After more than 30 years, genetics treatment trailblazer James Wilson M.D., Ph.D., is leaving the C...
.As biotechs try to turn a fresh webpage in August, at least three business have lost team in attemp...
.Professional equity capital firm venBio has actually elevated yet another half a billion dollars to...
.Otsuka Drug has actually grabbed Boston-based Jnana Rehabs for $800 thousand so the Oriental biotec...
.FibroGen is actually drastically reorganizing its business, giving up 75% of its U.S. staff and cea...
.Tracon Pharmaceuticals has determined to relax procedures weeks after an injectable immune system g...
.Ideaya Biosciences is actually wagering $400 million in biobucks that a bispecific antibody-drug co...